These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 9066336)
21. Differential nitric oxide synthase activity, cofactor availability and cGMP accumulation in the central nervous system during anaesthesia. Galley HF; Le Cras AE; Logan SD; Webster NR Br J Anaesth; 2001 Mar; 86(3):388-94. PubMed ID: 11573530 [TBL] [Abstract][Full Text] [Related]
22. Halothane but not isoflurane attenuates interleukin 1beta-induced nitric oxide synthase in vascular smooth muscle. Maeda H; Iranami H; Yamamoto M; Ogawa K; Morikawa Y; Senba E; Hatano Y Anesthesiology; 2001 Aug; 95(2):492-9. PubMed ID: 11506125 [TBL] [Abstract][Full Text] [Related]
23. Isoflurane and halothane attenuate endothelium-dependent vasodilation in rat coronary microvessels. Park KW; Dai HB; Lowenstein E; Darvish A; Sellke FW Anesth Analg; 1997 Feb; 84(2):278-84. PubMed ID: 9024015 [TBL] [Abstract][Full Text] [Related]
24. Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration. Adachi T; Shinomura T; Nakao S; Kurata J; Murakawa M; Shichino T; Seo N; Mori K Anesth Analg; 1995 Oct; 81(4):862-5. PubMed ID: 7574024 [TBL] [Abstract][Full Text] [Related]
25. NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857. Hu PS; Ross SB Pharmacol Toxicol; 1997 Feb; 80(2):97-102. PubMed ID: 9060041 [TBL] [Abstract][Full Text] [Related]
26. Vascular effects of halothane and isoflurane: cGMP dependent and independent actions. Jing M; Hart JL; Masaki E; Van Dyke RA; Bina S; Muldoon SM Life Sci; 1995; 56(1):19-29. PubMed ID: 7830493 [TBL] [Abstract][Full Text] [Related]
27. Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis. Vallebuona F; Raiteri M Eur J Neurosci; 1995 Apr; 7(4):694-701. PubMed ID: 7542528 [TBL] [Abstract][Full Text] [Related]
28. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices. Stepień A; Chalimoniuk M; Strosznajder J Cephalalgia; 1999 Dec; 19(10):859-65. PubMed ID: 10668104 [TBL] [Abstract][Full Text] [Related]
29. D-serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis. Fedele E; Bisaglia M; Raiteri M Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):43-7. PubMed ID: 9007841 [TBL] [Abstract][Full Text] [Related]
30. Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo. Cauli O; González-Usano A; Agustí A; Felipo V Neuroscience; 2011 Sep; 190():27-36. PubMed ID: 21703332 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of nitric oxide gas and nitric oxide donors on depolarization-induced release of [3H]norepinephrine from rat hippocampal slices. Stout AK; Woodward JJ Neuropharmacology; 1994 Nov; 33(11):1367-74. PubMed ID: 7532819 [TBL] [Abstract][Full Text] [Related]
32. Ketamine inhibits glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. Gonzales JM; Loeb AL; Reichard PS; Irvine S Anesthesiology; 1995 Jan; 82(1):205-13. PubMed ID: 7832303 [TBL] [Abstract][Full Text] [Related]
33. NMDA receptor-dependent nitric oxide and cGMP synthesis in brain hemispheres and cerebellum during reperfusion after transient forebrain ischemia in gerbils: effect of 7-Nitroindazole. Chalimoniuk M; Strosznajder J J Neurosci Res; 1998 Dec; 54(5):681-90. PubMed ID: 9843159 [TBL] [Abstract][Full Text] [Related]
34. Novel action of nitric oxide as mediator of N-methyl-D-aspartate-induced phosphatidylinositol hydrolysis in neonatal rat cerebellum. Smith SS; Li J Mol Pharmacol; 1993 Jan; 43(1):1-5. PubMed ID: 8380882 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Bredt DS; Snyder SH Proc Natl Acad Sci U S A; 1989 Nov; 86(22):9030-3. PubMed ID: 2573074 [TBL] [Abstract][Full Text] [Related]
36. Metabotropic glutamate receptor 5, but not 1, modulates NMDA receptor-mediated activation of neuronal nitric oxide synthase. Llansola M; Felipo V Neurochem Int; 2010 Mar; 56(4):535-45. PubMed ID: 20043967 [TBL] [Abstract][Full Text] [Related]
37. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213 [TBL] [Abstract][Full Text] [Related]